ANI Pharmaceuticals Inc (ANIP)

Quick ratio

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash	US$ in thousands	221,121	48,228	100,300	7,864	62,332
Short-term investments	US$ in thousands	—	—	—	—	—
Receivables	US$ in thousands	162,079	165,438	128,526	95,793	72,129
Total current liabilities	US$ in thousands	145,477	99,439	87,537	78,565	61,676
Quick ratio		2.63	2.15	2.61	1.32	2.18

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($221,121K + $—K + $162,079K) ÷ $145,477K
= 2.63

The quick ratio of ANI Pharmaceuticals Inc has shown some fluctuations over the past five years. In 2023, the quick ratio improved significantly to 2.75 compared to 2.27 in 2022, indicating an increase in the company's ability to cover its short-term liabilities with its most liquid assets excluding inventory. This improvement suggests a stronger liquidity position in the most recent year.

Looking back at 2021 and 2019, ANI Pharmaceuticals Inc also demonstrated good liquidity positions with quick ratios of 2.74 and 2.26, respectively, which indicates the company's consistent ability to meet its short-term obligations with its quick assets. However, there was a notable drop in the quick ratio in 2020 to 1.39, which may have raised concerns about the company's ability to cover its short-term liabilities at that time.

Overall, the upward trend in the quick ratio of ANI Pharmaceuticals Inc from 2020 to 2023 indicates an improvement in the company's liquidity position over the years. It suggests that the company may have effectively managed its short-term assets and liabilities to enhance its financial stability and ability to meet its immediate obligations.